Stocksigma LogoStocksigma Logo

Fredun Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 26,764 (+84.2% YoY | +17.3% QoQ) ■ EBITDA: 4,236 (+89.7% YoY | +29.4% QoQ) ■ EBITDA Margin (%): 15.8 (+46 bps YoY | +148 bps QoQ) ■ PAT: 1,857

Fredun Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Fredun Pharmaceuticals Ltd · Outcome · 05 Nov 2026, 4:55 pm

Fredun Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 26,764 (+84.2% YoY | +17.3% QoQ) ■ EBITDA: 4,236 (+89.7% YoY | +29.4% QoQ) ■ EBITDA Margin (%): 15.8 (+46 bps YoY | +148 bps QoQ) ■ PAT: 1,857 (+96.9% YoY | +41.4% QoQ) ■ EPS (INR): 10.9 (+39.3% QoQ)

Original exchange filing (PDF)

More announcements from Fredun Pharmaceuticals Ltd

All Fredun Pharmaceuticals Ltd announcements